These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 3582605

  • 1. Treatment of multiple myeloma with an intensive 5-drug combination or intermittent melphalan and prednisone; a randomised multicentre trial. Finnish Leukaemia Group.
    Palva IP, Ahrenberg P, Ala-Harja K, Almqvist A, Apajalahti J, Hallman H, Hänninen A, Ilvonen M, Isomaa B, Järvenpää E.
    Eur J Haematol; 1987 Jan; 38(1):50-4. PubMed ID: 3582605
    [Abstract] [Full Text] [Related]

  • 2. Treatment of multiple myeloma in old patients. Finnish Leukaemia Group.
    Palva IP, Ahrenberg P, Ala-Harja K, Almqvist A, Hänninen A, Ilvonen M, Isomaa B, Jouppila J, Järvenpää E, Kilpi H.
    Eur J Haematol; 1989 Oct; 43(4):328-31. PubMed ID: 2583258
    [Abstract] [Full Text] [Related]

  • 3. Corticosteroid is not beneficial in multiple-drug combination chemotherapy for multiple myeloma. Finnish Leukaemia Group.
    Palva IP, Ala-Harja K, Almqvist A, Elonen E, Hallman H, Hänninen A, Ilvonen M, Isomaa B, Jouppila J, Järvenpää E.
    Eur J Haematol; 1993 Aug; 51(2):98-101. PubMed ID: 8370425
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].
    Le Loët X, Monconduit M, Menard JF, Deshayes P, Grobois B, Tanguy A, Prevost E, Piguet H.
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):263-7. PubMed ID: 6740189
    [Abstract] [Full Text] [Related]

  • 10. Aggressive combination chemotherapy in multiple myeloma. A multicentre trial. Finnish Leukaemia Group.
    Scand J Haematol; 1985 Aug; 35(2):205-9. PubMed ID: 3901244
    [Abstract] [Full Text] [Related]

  • 11. Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
    Bladé J, San Miguel JF, Fontanillas M, Esteve J, Maldonado J, Alcalá A, Brunet S, García-Conde J, Besalduch J, Moro MJ, Fernández-Calvo J, Conde E, Font L, Gardella S, Carnero M, Carbonell F, Martí JM, Hernández-Martín J, Ortega F, Besses C, Ribera JM, Trujillo J, Escudero ML, Rozman C, Estapé J, Montserrat E.
    Hematol J; 2001 Aug; 2(4):272-8. PubMed ID: 11920260
    [Abstract] [Full Text] [Related]

  • 12. Phase III study of intermittent 5-drug regimen (VBCMP) versus intermittent 3-drug regimen (VMP) versus intermittent melphalan and prednisone (MP) in myelomatosis.
    Hansen OP, Clausen NA, Drivsholm A, Laursen B.
    Scand J Haematol; 1985 Nov; 35(5):518-24. PubMed ID: 3911373
    [Abstract] [Full Text] [Related]

  • 13. Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patients.
    Bladé J, San Miguel JF, Alcalá A, Maldonado J, Sanz MA, García-Conde J, Moro MJ, Alonso C, Besalduch J, Zubizarreta A.
    J Clin Oncol; 1993 Jun; 11(6):1165-71. PubMed ID: 8501503
    [Abstract] [Full Text] [Related]

  • 14. Alternating combination chemotherapy (VMCP/VBAP) is not superior to melphalan/prednisone in the treatment of multiple myeloma patients stage III--a randomized study from MGCS.
    Osterborg A, Ahre A, Björkholm M, Björeman M, Brenning G, Gahrton G, Gyllenhammar H, Johansson B, Juliusson G, Järnmark M.
    Eur J Haematol; 1989 Jul; 43(1):54-62. PubMed ID: 2670605
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of melphalan and prednisone versus melphalan, prednisone, cyclophosphamide, MeCCNU, and vincristine in untreated multiple myeloma.
    Pavlovsky S, Saslavsky J, Tezanos Pinto M, Palmer L, Curuchet M, Lein JM, Garay G, Dragosky M, Quiroga-Micheo E, Huberman AB.
    J Clin Oncol; 1984 Jul; 2(7):836-40. PubMed ID: 6376722
    [Abstract] [Full Text] [Related]

  • 16. Alternating combination chemotherapy COP (cyclophosphamide, vincristine, prednisone) and MP (melphalan, prednisone) in multiple myeloma: a multicenter phase II study (JCOG8906). Lymphoma Study Group of the Japan Clinical Oncology Group.
    Takenaka T, Shirakawa S, Mikuni C, Sai T, Shimamoto Y, Araki K, Hirano M, Miura A, Ohno Y, Ichimaru M, Hanada S, Inaba S, Konishi H, Toki H, Tajima K, Niimi M, Fukuda H, Shimoyama M.
    Jpn J Clin Oncol; 1999 Oct; 29(10):485-9. PubMed ID: 10645803
    [Abstract] [Full Text] [Related]

  • 17. [Multiple myeloma with high tumoral mass. Treatment combining melphalan, cyclophosphamide, vincristine, CCNU and prednisone. 35 cases].
    Brun B, Kuentz M, Man NG, Feuilhade F, Bierling P, Vernant JP, Farcet JP, Cordonnier C, Reyes F, Dreyfus B, Rochant H.
    Presse Med; 1983 Apr 30; 12(19):1205-10. PubMed ID: 6221296
    [Abstract] [Full Text] [Related]

  • 18. Vincristine and prednisone prolong the survival of patients receiving intravenous or oral melphalan for multiple myeloma: Cancer and Leukemia Group B experience.
    Cornwell GG, Pajak TF, Kochwa S, McIntyre OR, Glowienka LP, Brunner K, Rafla S, Coleman M, Cooper MR, Henderson E.
    J Clin Oncol; 1988 Sep 30; 6(9):1481-90. PubMed ID: 3047338
    [Abstract] [Full Text] [Related]

  • 19. Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experience.
    Cornwell GG, Pajak TF, Kochwa S, McIntyre OR, Glowienka LP, Brunner K, Rafla S, Silver RT, Cooper MR, Henderson E, Kyle RA, Haurani FI, Cuttner J.
    Cancer; 1982 Nov 01; 50(9):1669-75. PubMed ID: 7116299
    [Abstract] [Full Text] [Related]

  • 20. Improved long-term survival in multiple myeloma. Finnish Leukaemia Group.
    Eur J Haematol; 1989 Nov 01; 43(5):385-8. PubMed ID: 2612611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.